BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 59 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2022. The put-call ratio across all filers is 2.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $273,838 | +5.0% | 144,888 | 0.0% | 0.07% | +4.4% |
| Q4 2022 | $260,798 | -35.6% | 144,888 | -39.6% | 0.07% | -29.2% |
| Q3 2022 | $405,000 | -31.4% | 239,888 | 0.0% | 0.10% | -41.5% |
| Q2 2022 | $590,000 | -11.1% | 239,888 | 0.0% | 0.16% | -7.9% |
| Q1 2022 | $664,000 | -48.1% | 239,888 | 0.0% | 0.18% | -23.6% |
| Q4 2021 | $1,279,000 | -39.2% | 239,888 | -3.5% | 0.23% | -28.5% |
| Q3 2021 | $2,102,000 | +50.4% | 248,506 | +469.8% | 0.33% | +169.4% |
| Q4 2020 | $1,398,000 | – | 43,615 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $8,487,000 | 0.44% |
| Hawkeye Capital Management, LLC | 243,009 | $598,000 | 0.33% |
| Boxer Capital, LLC | 2,014,858 | $4,957,000 | 0.31% |
| Newtyn Management, LLC | 520,000 | $1,279,000 | 0.24% |
| Artal Group S.A. | 1,646,517 | $4,050,000 | 0.22% |
| DAFNA Capital Management LLC | 313,600 | $771,000 | 0.21% |
| RA Capital Management | 2,589,904 | $6,371,000 | 0.17% |
| Bellevue Group AG | 4,717,113 | $11,605,000 | 0.16% |
| MPM BioImpact LLC | 239,888 | $590,000 | 0.16% |
| K2 PRINCIPAL FUND, L.P. | 507,652 | $1,249,000 | 0.14% |